Intervention News

Healio | Cardiology Today compiled a list of some of the most important news in cardiology from 2023.

The subset of patients with high-risk pulmonary embolism who had hemodynamic collapse had an in-hospital mortality rate of 42%, according to a retrospective analysis of a large registry.

When choosing a structure for a practice, you are making two choices: what legal structure to choose and which tax treatment to select.

In November, the FDA approved two renal denervation devices for people with uncontrolled hypertension despite maximally tolerated therapies. The approvals ushered in the first-ever interventional procedures with indications to lower BP.

A novel deep learning algorithm applied to a single preoperative ECG improved risk prediction for death after cardiac surgery and other inpatient procedures for a large cohort, researchers reported.

A consensus statement outlines best practices and competencies for cardiac catheterization in pediatric patients and adults with congenital heart disease, reflecting an evolution in practice for patients with unique procedural requirements.

Intravascular imaging-guided PCI showed benefit vs. angiography for patients with left main CAD, with significantly lower risk for cardiac death or spontaneous target vessel-related MI, researchers reported.

As we approach the year end, many investors, including physicians, will review their portfolios and assess the last 12 months of performance.

It seems long ago now that so much has changed, but just a few decades ago, interventional cardiologists, electrophysiologists and others who work daily with X-ray machines lived in a very different world.

During an introductory press briefing, new NIH Director Monica M. Bertagnolli, MD, FACS, FASCO, called for a greater focus in clinical research to improve access to care.